Faster Cancer-Fighting cells tested in groundbreaking trial
Disease control
Not yet recruiting
This is a first-in-human study to test the safety of a new, experimental CAR-T cell therapy called UF-KURE-BCMA for patients with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified in a lab to t…
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC